TD Cowen Initiates Coverage On Enliven Therapeutics with Outperform Rating
TD Cowen analyst Phil Nadeau initiates coverage on Enliven Therapeutics (NASDAQ:ELVN) with a Outperform rating.
Stocks That Hit 52-Week Lows On Monday
During Monday's session, 56 companies made new 52-week lows.